Great Place To Work Reveals Southeast Asia's Best Workplaces in Healthcare & Biopharma

Great Place To Work, the global authority on workplace culture, announced the inaugural Southeast Asia's Best Workplaces in Healthcare & Biopharma 2026 list — a landmark recognition honouring 15 outstanding organizations that have set the benchmark for trust, care, innovation, and performance across one of the region's most strategically important sectors.

As Asia's healthcare market heads toward an estimated value of USD 5 trillion by 2030, projected to contribute nearly 40% of global healthcare growth, Southeast Asia is emerging as a critical hub for healthcare delivery, medical innovation, and life sciences investment. The region's biopharmaceutical market alone is expected to almost double from approximately USD 6.7 billion in the mid-2020s to nearly USD 12.8 billion over the coming decade, driven by growing demand for advanced therapies, vaccines, biologics, and healthcare services.

Amid this rapid expansion, the organizations recognized on this year's list are helping shape the future of healthcare across Southeast Asia. From hospitals and healthcare providers to biopharma and MedTech organizations, they are expanding access to care, accelerating innovation, and strengthening health systems to meet the needs of aging populations and rising chronic disease burdens.

"Healthcare and biopharma organizations are the human part of Southeast Asia's growth story. As demand for care rises and new treatments emerge, what sets the best organizations apart is not only the quality of their science or services, but the culture that supports the people behind them. The organizations recognised on this year's Southeast Asia's Best Workplaces in Healthcare & Biopharma list demonstrate that when you build high-trust workplaces, you unlock innovation, improve patient outcomes, and become a force for strengthening health systems across the region," said Evelyn Kwek, Managing Director, Great Place To Work ASEAN & ANZ